Skip to content

AVAI BIO, INC.

AVAI

CIK 0001740797

← back to feed
Revenue (TTM)
$276.32K
Q3 Feb 2026
Net Income (TTM)
−$1.95M
+46.3% YoY Q3 Feb 2026
EPS Diluted (TTM)
—
Q3 Feb 2026
Gross Margin
91.0%
Q3 Feb 2026
Operating Margin
-377.1%
Q3 Feb 2026
Net Margin
-704.5%
Q3 Feb 2026
Free Cash Flow (TTM)
—
Q3 Feb 2026
Cash
$50.4K
Q3 Feb 2026
Total Debt
$30K
Q3 Feb 2026
Shares Outstanding
138.25M sh
Q3 Feb 2026

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings